Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Is Amneal a Buy Before Rytary Generic Erosion?
01:01pm, Tuesday, 09'th Jun 2026
AMRX faces Rytary generic pressure in 2026, but growth in generics, injectables, biosimilars, and higher profitability targets could support its outlook.
What's Driving Amneal's 2026 Growth Outlook?
12:56pm, Tuesday, 09'th Jun 2026
AMRX's 2026 outlook is driven by higher profit expectations, a steady launch cadence, and growth from complex generics, injectables, and specialty brands.
Here's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth Stock
10:45am, Monday, 08'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Amneal Stock Up on FDA Nod for Romidepsin Injection Solution
12:30pm, Friday, 05'th Jun 2026
AMRX gains after FDA approval of ready-to-use romidepsin injection, with 180-day exclusivity and a potential boost to its injectables portfolio.
BRIDGEWATER, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced new positive interim results from its ongoing Phas
Amneal Pharmaceuticals gets FDA approval for romidepsin injection solution
02:08pm, Thursday, 04'th Jun 2026
Amneal Pharmaceuticals (NASDAQ:AMRX) said on Thursday the US Food and Drug Administration has approved its romidepsin injection solution, 27.5 mg/5.5 mL, in single-dose, ready-to-use vials. The produc
Amneal Pharmaceuticals gets FDA approval for romidepsin injection solution
10:00am, Thursday, 04'th Jun 2026
Amneal Pharmaceuticals (NASDAQ:AMRX) said on Thursday the US Food and Drug Administration has approved its romidepsin injection solution, 27.5 mg/5.5 mL, in...
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
08:00am, Thursday, 04'th Jun 2026
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity an
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
10:42am, Monday, 01'st Jun 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
08:00am, Monday, 01'st Jun 2026
BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and Presiden
Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?
01:16pm, Tuesday, 26'th May 2026
AMRX is building momentum with growth across specialty drugs and biosimilars, supported by new launches and a diversified portfolio.
A Look at Amneal Pharmaceuticals Inc (AMRX) After 3.6% Gain -- GF Value $7.57 vs Price $12.21
09:15pm, Wednesday, 20'th May 2026
On May 20, 2026, Amneal Pharmaceuticals Inc (AMRX) shares rose 3.6%, closing at $12.21. This move comes amid a 52-week price range of $7.02 to $15.42, highlight
Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term
10:45am, Monday, 18'th May 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)
01:46pm, Friday, 15'th May 2026
Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?
10:41am, Friday, 15'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
